1. Intravitreal and posterior subtenon triamcinolone acetonide for severe acute posterior multifocal placoid pigment epitheliopathy.
- Author
-
Vianna RNG, Vanzan V, Turchetti R, and Burnier MN Jr
- Subjects
- Fluorescein Angiography, Humans, Male, Time Factors, Tomography, Optical Coherence methods, Treatment Outcome, Visual Acuity, White Dot Syndromes diagnostic imaging, White Dot Syndromes pathology, Young Adult, Anti-Inflammatory Agents administration & dosage, Intravitreal Injections methods, Tenon Capsule, Triamcinolone Acetonide administration & dosage, White Dot Syndromes drug therapy
- Abstract
A 21-year-old man presented with visual acuity of 20/200 in both eyes. The fundus picture, fluorescein angiography, and optical coherence tomography revealed severe bilateral acute posterior multifocal placoid pigment epitheliopathy and serous macular detachments. We treated the patient with triamcinolone acetonide, an intravitreal injection (4 mg/0.1 mL) in one eye and a posterior subtenon injection (40 mg/1 mL) in the other eye. Within 2 weeks the visual acuity was 20/80 in both eyes. At the 8-week follow-up visit his vision was 20/63 bilaterally. One year later the vision remained 20/63 in both eyes. In this patient, the triamcinolone acetonide injections, whether administered intravitreally or via the posterior subtenon route, achieved similar anatomic and functional recovery results.
- Published
- 2019
- Full Text
- View/download PDF